ADHD is one of the most common childhood disorders, appearing in children of all ages and often persisting through adolescence and into adulthood. Marked by unusual difficulties in paying attention and hyperactivity, the causes of ADHD are thought to be genetic (inherited) and/or environmental.
Symptoms of ADHD include inability to pay attention to detail, stay on task, or follow directions, consistently making careless mistakes, task avoidance (especially if the task is perceived as difficult), distractibility, and forgetfulness. Hyperactivity can include fidgeting, squirming, excessive physical activity at inappropriate times, nonstop chattering, and impulsive or impatient behavior.
When symptoms such as these persist for at least six months and cause significant disruption in the individual’s school, work, or home life, a diagnosis of ADHD is possible.
ADHD has no known cure at this time, and is managed by treating the symptoms with medication and therapeutic support.
Artemis Institute for Clinical Research conducts clinical trials of investigative medications for the treatment of ADHD in children (age 6 or older), adolescents, and adults. Qualified people participating in a trial may be eligible to receive financial compensation for time and travel, study-related medical and psychological evaluations, and the investigative study medication at no cost.
If you or your child has experienced some or all of the symptoms described and would like to volunteer for a study, or if you know someone suffering from ADHD who may want to volunteer, please send us your request using the Join a Study form, or call us toll-free at 855-DoStudies (855.367.8834).